Stenner V J, Mackay B, King T, Barrs V R D, Irwin P, Abraham L, Swift N, Langer N, Bernays M, Hampson E, Martin P, Krockenberger M B, Bosward K, Latter M, Malik R
University of Queensland Veterinary Teaching Hospital, Queensland, Brisbane, Australia.
Med Mycol. 2007 May;45(3):249-66. doi: 10.1080/13693780601187158.
Systemic protothecosis was diagnosed in 17 Australian dogs between 1988 and 2005. There was a preponderance of young-adult (median 4 years), medium- to large-breed dogs. Females (12/17 cases) and Boxer dogs (7 cases, including 6 purebreds and one Boxer cross) were over-represented. Sixteen of 17 dogs died, with a median survival of four months. A disproportionate number of cases were from coastal Queensland. In most patients, first signs were referable to colitis (11/17 cases), which varied in severity, and was often present for many months before other symptoms developed. Subsequent to dissemination, signs were mostly ocular (12 cases) and/or neurologic (8 cases). Two dogs had signs due to bony lesions. Once dissemination was evident, death or euthanasia transpired quickly. Prototheca organisms had a tropism for the eye, central nervous system (CNS), bone, kidneys and myocardium, tissues with a good blood supply. Microscopic examination and culture of urine (5 cases), cerebrospinal fluid (CSF;1 case), rectal scrapings (4 cases), aspirates or biopsies of eyes (5 cases) and histology of colonic biopsies (6 cases) as well as skin and lymph nodes (2 cases) helped secure a diagnosis. Of the cases where culture was successful, P wickerhamii was isolated from two patients, while P zopfii was isolated from five. P zopfii infections had a more aggressive course. Treatment was not attempted in most cases. Combination therapy with amphotericin B and itraconazole proved effective in two cases, although in one of these treatment should have been for a longer duration. One surviving dog is currently still receiving itraconazole. Protothecosis should be considered in all dogs with refractory colitis, especially in female Boxers.
1988年至2005年间,17只澳大利亚犬被诊断患有全身性原壁菌病。以年轻成年犬(中位年龄4岁)、中大型犬为主。雌性犬(12/17例)和拳师犬(7例,包括6只纯种犬和1只拳师犬混血)占比过高。17只犬中有16只死亡,中位生存期为4个月。病例数量不成比例地多来自昆士兰沿海地区。大多数病犬最初症状归因于结肠炎(11/17例),严重程度各异,且在出现其他症状前常持续数月。播散后,症状大多为眼部(12例)和/或神经症状(8例)。两只犬因骨病变出现症状。一旦播散明显,很快就会死亡或实施安乐死。原壁菌对眼睛、中枢神经系统(CNS)、骨骼、肾脏和心肌等血供良好的组织有嗜性。对尿液(5例)、脑脊液(CSF;1例)、直肠刮片(4例)、眼内抽吸物或活检组织(5例)以及结肠活检组织(6例)以及皮肤和淋巴结(2例)进行显微镜检查和培养有助于确诊。在培养成功的病例中,从两名患者中分离出威克汉姆原壁菌,从五名患者中分离出佐夫原壁菌。佐夫原壁菌感染病程更具侵袭性。大多数病例未尝试治疗。两性霉素B和伊曲康唑联合治疗在两例中被证明有效,尽管其中一例治疗疗程应更长。一只存活犬目前仍在接受伊曲康唑治疗。所有患有难治性结肠炎的犬,尤其是雌性拳师犬,都应考虑原壁菌病。